Protein shakes tested to curb addiction cravings in small hospital study
NCT ID NCT06459609
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tested whether adding protein supplements twice a day could reduce cravings in 28 people hospitalized for addiction. Participants spent one week with protein and one week without, rating their cravings on a simple scale. The goal was to see if a simple dietary change might help during early recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
protein supplement (powder mixed with yogurt or compote)
What this could lead to
If it works, this could point toward a simple dietary aid to help manage cravings during early addiction treatment.
What could go wrong
This is a very small pilot study (28 people) with no control group and short duration. Results may not apply to everyone or lead to a proven treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADDICTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH de Pau
Pau, 64000, France